1.
Witkowska M, Witkowska S, Klimczak M, Frydecka A, Witkowski M, Smolewski P. Quality of life patients treated with rituximab intravenous versus subcutaneous in B-cell lymphomas: results from outpatient Hematooncology Clinic in Lodz. OncoReview [Internet]. 2021Jul.14 [cited 2021Oct.16];11(2(42):33-9. Available from: https://www.journalsmededu.pl/index.php/OncoReview/article/view/1318